Please do not adjust margins
Dalton Transactions
Page 9 of 13
DOI: 10.1039/C6DT00984K
Journal Name
ARTICLE
8.26 (d, J = 8.8 Hz, 4H, ArH), 7.68 (d, J = 8.8Hz, 4H, ArH), 7.39-
7.33 (m, J = 8.4 Hz, 4H, ArH), 7.27 (2H, ArH), 7.23 (d, J = 2.0 Hz,
2H, ArH), 6.78 (d, J = 2.4 Hz, 2H, ArH), 6.21 (dd, J = 9.2, 4.4 Hz,
2H, CHCy), 5.96 (d, J = 14.8 Hz, 4H, CH2), 5.75 (d, J = 14.8 Hz,
4H, CH2), 5.10 (d, J = 14.0 Hz, 4H, CH2), 4.96 (d, J = 14.0 Hz, 4H,
CH2), 3.34 (s, 6H, CH3), 2.93 (m, 2H, CH2), 1.46 (m, 2H, CH2),
2.04 - 1.93 (m, 4H, CH2), 1.38 (s, 18H, CH3), 0.82 (s, 18H, CH3).
13C NMR (100 MHz, CDCl3): δ 152.9 (CAr-O), 147.8 (CAr-NO2),
147.6 (CAr-NO2), 143.8 (CAr-CH2), 142.6 (CAr-CH3), 140.5 (CAr),
131.7 (CAr-But), 131.1 (CAr-But), 130.0 (CAr-But), 127.7 (CHAr),
127.1 (CHAr), 126.3 (CAr-CH3), 125.6 (CHAr), 125.5 (CHAr), 124.2
(CHAr), 123.9 (CHAr), 111.8 (CHAr), 111.1 (CHAr),75.8 (CH2O),
61.1 (CH), 46.5 (CH2N), 36.1 (CBut), 35.5 (CBut), 34.3 (CBut), 31.2
(CH3 But), 31.0 (CH2), 23.9 (CH2), 21.0 (CH3).
HRMS (positive ions): m/z 961.4820, 879.5567 (calcd for [M–
Br]+ 961.4818, [M–2Br-H]+ 879.5577). 1H NMR (400 MHz,
CDCl3): δ 13.05 (s, 2H, NCHN), 9.47 (d, J = 8.4 Hz , 2H, ArH),
8.54 (s, 2H, ArH), 8.26 (d, J = 7.4 Hz, 4H, ArH), 7.70 (t, J = 5.0
Hz, 2H, ArH), 7.57 (d, J = 4.4 Hz, 2H, ArH) 7.44 (t, J = 7.8 Hz,
2H, ArH), 7.30 - 7.20 (m, 8H, ArH), 7.16 - 7.14 (m, 2H, CH),
5.74 (d, J = 14.4 Hz, 2H, CH2), 5.63 (d, J = 10.4 Hz, 2H, CH2),
3.79 (s, 6H, CH3), 1.21 (s, 18H, CH3), 1.05 (s, 18H, CH3). 13C
NMR (100 MHz, CDCl3): δ 155.5 (CAr-O), 147.3 (CAr), 142.5
(CHimidazolium), 133.6 (CAr), 129.5 (CHAr), 128.8 (CHAr), 128.1
(CHAr), 127.5 (CHAr), 125.9 (CHAr), 125.3 (CAr-CH2), 116.8 (CHAr),
113.1 (CHAr), 64.6 (CH), 64.0 (CH2O), 47.4 (CH2N), 35.1 (CBut),
34.4 (CBut), 31.2 (CH3 But), 30.9 (CH3 But).
(R,R)-17. Compound 17 was prepared from (R,R)-4 (207 mg,
(R,R,Rp,Rp)-14. Compound 14 was prepared from (R,R)-1b
(172 mg, 0.50 mmol) and Rp-9B (400 mg, 1.33 mmol) as a
white solid. Yield: 142 mg (30%). Anal. Calcd for C56H58Br2N4
(M = 946.8945 g mol–1): C, 71.03; H, 6.17; N, 5.92; Found: C,
70.94; H, 6.11; N, 6.03. HRMS (positive ions): m/z 865.3850,
785.4596 (calcd for [M – Br]+ 865.3845, [M–2Br-H]+ 785.4583.)
1H NMR (400 MHz, (CD3)SO): δ 9.78 (s, 2H, NCHN), 7.72 (d, J =
8.40 Hz, 2H, ArH), 7.60 - 7.56 (m, 2H, ArH), 7.42 (d, J = 7.44 Hz,
2H, ArH), 6.70 - 6.68 (m, 2H, ArH), 6.43 - 6.42 (m, 4H), 6.25 (d,
J = 7.0 Hz, 2H), 5.85 - 5.84 (m, 2H, CH), 5.40 (d, J =1 4.8 Hz, 2H,
CH2), 5.18 (d, J = 14.4 Hz, 2H, CH2), 2.93 - 2.69 (m, 18H), 2.50 -
2 .41 (m, 4H, CH2), 1.67 - 1.62 (m, 2H, CH2). 13C NMR (100MHz,
(CD3)SO): δ 141.0 (CH imidazolium), 139.6 (CAr), 139.2 (CAr), 138.4
(CAr), 135.7 (CAr), 134.8 (CAr), 133.7 (CAr), 133.3 (CAr), 132.6
(CAr), 132.0 (CAr), 131.9 (CAr), 130.8 (CHAr), 129.9 (CHAr), 129.7
(CHAr), 127.6 (CHAr), 125.3 (CHAr), 114.5 (CHAr), 60.6 (CH), 49.7
(CH2N), 34.9 (CH2), 34.7 (CH2), 34.1 (CH2), 24.2 (CH2), 19.2
(CH3).
0.50 mmol) and benzyl bromide 9D (306 mg, 1.33 mmol) as a
white solid (eluent: EtOAc/CH2Cl2/CH3OH/PE = 8/2/1/2). Yield:
339 mg (80%). Anal. Calcd for C42H34Br2N6O4 (M = 846.5652 g
mol–1): C, 59.59; H, 4.05; N, 9.93; Found: C, 59.55; H, 4.01; N,
10.02. HRMS (positive ions): m/z 765.1826, 685.2567 (calcd
for [M–Br]+ 765.1825, [M–2Br-H]+ 685.2563). 1H NMR (400
MHz, CDCl3): δ 13.27 (s, 2H, NCHN), 9.61 (d, J = 8.6 Hz, 2H,
ArH), 8.35 (s, 2H, ArH), 8.26 (d, J = 7.5 Hz, 4H, ArH), 7.82 -
7.77 (m, 6H, ArH), 7.63 (t, J = 7.8 Hz, 2H, ArH), 7.47 (d, J = 8.4
Hz, 2H, ArH), 7.40 (d, J = 8.6 Hz, 4H, ArH), 7.34 - 7.30 (m, 4H,
ArH), 7.25 (t, J = 7.4 Hz, 2H, CH), 5.85 (d, J = 15.2 Hz, 2H, CH2),
5.66 (d, J=15.2 Hz, 2H, CH2). 13C NMR (100 MHz, CDCl3): δ
148.1 (CAr-NO2), 141.8 (CHimidazolium), 138.8 (CAr), 132.7 (CAr-CH2),
131.6 (CAr), 130.2 (CAr), 129.9 (CAr), 129.0 (CAr), 128.8 (CHAr),
128.7 (CHAr), 128.4 (CHAr), 124.2 (CHAr), 117.2 (CHAr), 112.0
(CHAr), 65.8 (CH), 50.1 (CH2N).
(R,R)-18. Compound 18 was prepared from (R,R)-8e (207
mg, 0.50 mmol) and 9E (294 mg, 1.33 mmol) as a white solid
(eluent: EtOAc/CH2Cl2/CH3OH/PE = 8/2/1/2). Yield: 321 mg
(75%). Anal. Calcd for C50H40Br2N4 (M = 856.6874 g mol–1): C,
70.10; H, 4.71; N, 6.54; Found: C, 69.93; H, 4.65; N, 6.62.
HRMS (positive ions): m/z 775.2450, 695.3216 (calcd for [M–
Br]+ 775.2436, [M–2Br-H]+ 695.3175). 1H NMR (400 MHz,
CDCl3): δ 13.04 (s, 2H, NCHN), 9.62 (d, J = 8.6 Hz, 2H, ArH),
8.44 - 8.40(m, 4H, ArH), 7.77 (br s, 16H, ArH), 7.61 - 7.59 (m,
4H, ArH), 7.55 - 7.51 (m, 2H, ArH), 7.46 - 7.27 (m, 2H, ArH),
7.23 - 7.19 (m, 2H, ArH), 6.96 (d, J = 8.5 Hz, 2H, CH2), 5.65 (d, J
= 14.9 Hz, 2H, CH2). 13C NMR (100 MHz, CDCl3): δ 141.6
(CHimidazolium), 133.2 (CAr), 133.1 (CAr), 132.8 (CAr), 131.8 (CAr),
130.1 (CAr), 129.8 (CAr), 129.6 (CAr), 129.3 (CAr), 129.2 (CAr),
128.3 (CHAr), 128.0 (CHAr), 127.8 (CHAr), 127.6 (CHAr), 127.6
(CHAr), 127.0 (CHAr), 126.8 (CHAr), 124.2 (CHAr), 116.7(CHAr),
112.4 (CHAr), 65.7 (CH), 51.8 (CH2N).
(R,R)-15. Compound 15 was prepared from (R,R)-
0.50 mmol) and 9A (577 mg, 1.33 mmol) as a white solid
(eluent: EtOAc/CH2Cl2/CH3OH 8/2/1). Anal. Calcd for
4 (207 mg,
=
C72H78Br2N6O6 (M = 1283.2343 g mol–1): C, 67.39; H, 6.13; N,
6.55; Found: C, 67.32; H, 6.10; N, 6.57. Yield: 603 mg (94 %).
HRMS (positive ions): m/z 1203.5128, 1121.5905 (calcd for
[M–Br]+ 1203.5146, [M–2Br-H]+1121.5911. 1H NMR (400 MHz,
CDCl3): δ 13.37 (s, 2H, NCHN), 9.52 - 9.50 (d, J = 8.4 Hz ,2H,
ArH), 8.46 (s, 2H, ArH), 8.28 - 8.20 (m, 8H, ArH), 7.72 - 7.68 (m,
6H, ArH), 7.50 - 7.42 (m, 4H, ArH), 7.27 - 7.21 (m, 6H, ArH),
7.15 - 7.11 (m, 2H, ArH), 7.04 (s, 2H, CH), 5.76 (d, J = 14.3 Hz,
2H, CH2), 5.65 (d, J = 8.4 Hz, 2H, CH2), 5.10 - 4.96 (m, 4H, CH2),
1.40 (s, 18H, CH3), 0.87(s, 18H, CH3). 13C NMR (100 MHz,
CDCl3) δ 151.9 (CAr-O), 147.3 (CAr-NO2), 146.7 (CAr-NO2), 142.6
(CAr), 141.5 (CHimidazolium), 140.4 (CAr), 132.8 (CAr-But), 130.9
(CHAr), 129.4 (CHAr), 128.6 (CHAr-NO2-m), 127.7 (CHAr), 127.5
(CHAr), 126.8 (CHAr), 126.0 (CHAr), 125.0 (CAr-CH2), 124.3 (CHAr),
123.8 (CHAr), 123.1(CHAr), 115.8 (CHAr), 111.8 (CHAr), 63.9
(CH2O), 45.2 (CH2N), 34.5 (CBut), 33.4 (CBut), 30.1 (CH3 But), 30.0
(CH3 But).
(aR)-19. Compound 19 was prepared from (aR)-8 (243 mg,
0.50 mmol) and 9A (577 mg, 1.33 mmol) as a white solid
(eluent: EtOAc/CH2Cl2/CH3OH/PE = 8/2/1/1). Yield: 528 mg
(78%). Anal. Calcd for C78H78Br2N6O6 (M = 1355.2985 g mol–1):
C, 69.12; H, 5.80; N, 6.20; Found: C, 69.09; H, 5.75; N, 6.24.
HRMS(positive ions): m/z 1275.5178, 1193.5917 (calcd for
[M–Br]+ 1275.5166, [M-2Br-H]+ 1193.5905). 1H NMR (400
MHz, CDCl3): δ 11.37 (s,2H,NCHN), 8.22 (d, J = 8.4 Hz, 6H,
ArH), 8.03 - 8.02 (m, 2H, ArH), 7.92 (d, J = 8.2, 2H, ArH), 7.76
(d, J = 7.8 Hz, 4H, ArH), 7.76 (d, J = 7.8 Hz, 4H, ArH), 7.53 -
(R,R)-16. Compound 16 was prepared from (R,R)-4 (207 mg,
0.50 mmol) and 9C (415 mg, 1.33 mmol) as a white solid
(eluent: EtOAc/CH2Cl2/CH3OH = 8/2/1). Yield: 442 mg (85%).
Anal. Calcd for C60H72Br2N4O2 (M = 1041.0473 g mol–1): C,
69.22; H, 6.97; N, 5.38; Found: C, 69.16; H, 6.87; N, 5.43.
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 9
Please do not adjust margins